应用脾腔分流联合断流术提高门脉高压症的疗效观察

Effects of splenocaval shunt combined with devascularization on improving curative efficacy for patients with portal hypertension

目的:探讨应用脾腔分流联合断流术提高门脉高压症的手术治疗效果。方法:对照分析135例施行脾腔分流联合断流术和120例接受单纯断流术的肝硬化门脉高压症患者的临床资料。结果:脾腔分流联合断流术后的再出血率、门静脉血栓形成率及腹水复发率均明显低于单纯断流术后,而断分流联合组术后肝性脑病发生率及原发性肝癌发生率与断流组无显著差异,围手术期死亡率两组无显著差异。结论:改良脾腔分流联合断流术提高了门脉高压症的疗效,为外科治疗门静脉高压症提供一个较好的思路。

Objective： To observe effects of splenocaval shunt combined with devascularization on improving efficacy for patients with portal hypertension.Methods： The clinical data of 135 patients having received the splenocacval shunt combined with devascularization（combined group） and 120 cases having received single devascularization procedure（control group） were comparatively analyzed.Results： The rebleeding rate,portal vein thrombosis rate and recurrence rate of ascites in combined group were all lower than those in control group;but the incidences of hepatic encephalopathy,primary hepatic cancer and perioperative mortality were not significantly different between the two groups.Conclusions： The splenocacval shunt combined with devascularization is a better choice in the treatment of portal hypertension for its safety and effectiveness.